SlideShare a Scribd company logo
1 of 20
Download to read offline
James Harper
Why are muscle relaxants used?
Facilitation of tracheal intubation
Rapid sequence induction
Paralysis important for certain types of surgery
E.g. abdominal
Prevents patient movement during delicate surgery
E.g. Neuro or ocular
Allows patient’s ventilation to be controlled
ITU
Muscle Relaxants
Depolarising
Suxamethonium
Rapid onset and offset
Not pharmacologically reversible
Numerous s/e and c/i
Non-depolarising
Compete with ACh for binding at the α subunit of the
nAChR
Blockade can be reversed with anticholinesterase
Drug Onset (s) Offset (min)
Suxamethonium 60 10
Atracurium 110 43
Mivacurium 170 16
Rocuronium 75 33
Vecuronium 180 33
Modified from Aitkenhead et al.
ACh e
ACh
NDMB
Neostig.
Neuromuscular monitoring
Allows indirect determination of neuromuscular
transmission
Should be performed whenever a NMB is used (Eriksson
et al. 2003)
Train-of-four (TOF) twitch response
Electric current applied in bursts of 4 to the ulnar nerve
Response in adductor policis measured
(acceleromyography)
NDMB causes fade in the amplitude of the twitches
4th
twitch affected first then 3nd
, 2nd
and 1st
Ratio of amplitude of 4th
:1st
twitch = TOF ratio
Train-of-four
TOF ratio for safe
extubation is 0.9 (Viby-
Mogensen 2000)
2nd
twitch must be visible
for anticholinesterase
reversal to be effective
(van Miert et al. 1997) Atracurium
Current problems
Sux. has rapid onset and offset but many s/e and often
c/i
What would the alternative be for R.S.I?
Rocuronium has rapid onset but in a ‘cannot intubate
cannot ventilate’ situation return to spontaneous breathing
is too slow
Reversal of profound ND blockade is not possible
PORC vs inadequate blockade
Lack NM monitoring despite recommendation →
unrecognised PORC (Grayling 2007, Eriksson 2003)
Reversal with neostigmine/edrophonium +
parasympatholytic cumbersome. CVS effects and PONV.
The answer – sugammadex?
A γ cyclodextrin molecule composed of 8 glucose mols
forming a ring
Designed to encapsulate aminosteroid NDMBs, especially
rocuronium (rocuronium>vecuronium>>pancuronium)
Sugammadex binds rocuronium v tightly and irreversibly
in a 1:1 ratio forming an H2O soluble complex
(Hunter et al. 2006)
(Naguib 2007)
Modifed from Naguib 2007
Sugammadex – mechanism of action
Sugammadex has its action in the plasma, not at the NMJ
Rocuronium is encapsulated in the plasma
Concentration gradient between free rocuronium in the
plasma and rocuronium at the NMJ
Rocuronium diffuses away from the NMJ into the plasma
where it is chelated by sugammadex
nAChRs become free at the NMJ allowing neuromuscular
transmission to resume
Gijsenbergh et al. 2005
Better than anticholinesterase?
Flockton et al. 2008
Compared time to recovery of TOF 0.9
 Rocuronium 0.6mgkg-1
followed by sugammadex 2mgkg-1
 Cisatracurium 0.15mgkg-1
followed by neostigmine 50μgkg-1
Reversal given at appearance of T2
Mean time to recovery
 Rocuronium/sugammadex 1.9 min
 Cisatracurium/neostigmine 9.0 min (p<0.0001)
Greater change in HR in neostigmine group (glycopyrrolate)
Reversal of profound block
Standard anticholinesterases only effective after
appearance of T2
Sparr et al. 2007
98 anaesthetised patients given rocuronium 0.6mgkg-1
Randomised to varying doses of sugammadex or placebo 3,
5 or 15 mins after rocuronium
Recovery to 0.9 TOF reduced from 52.1 mins to 1.8 mins
when 8mgkg-1
sugammadex given 3mins after rocuronium
Better than suxamethonium?
Naguib et al. 2007
Compare speed of recovery from 1.2mgkg-1
rocuronium
followed 3 mins later by 16mgkg-1
sugammadex with
spontaneous recovery from 1mgkg-1
suxmaethonium
Total onset-offest time is faster for
rocuronium/sugammadex (4min 47) than suxamethonium
(9min 23)
Suxamethonium produces superior intubating conditions
compared to rocuronium (Karcioglu et al. 2006)
Is sugammadex safe?
No serious adverse effects have been reported to date
QT ↑ (Gijsenbergh et al.), transient BP↓ (de Boer et al.) and
↑ urinary N-acetyl glucosaminidase (Flockton et al.)
Rocuronium/sugammadex excreted mainly in the urine
(Gijsenbergh et al.) – renal failure?
No known effect on any receptor system, no need for
anti-muscarinic – cardiovascular stability
Equally effective under maintenance anaesthesia with
propofol as sevoflurane (unlike neostigmine) (Vanacker
et al. 2007)
Applications
More rapid reversal than anticholinesterases with fewer
s/e
More rapid turnaround of surgical patients
Ability to antagonise a profound block
Larger doses of rocuronium can be used with confidence
Less PORC in the absence of neuromuscular monitoring
Rapid onset-offset of rocuronium/sugammadex
Could replace suxamethonium for R.S.I
Considerations
Ethical
Rocuronium and sugammadex manufactured by Organon
Temptation to rely on rocuronium
Consider the patient
Advancement for advancement’s sake or real benefits?
Economic
Potential to use larger doses of rocuronium
Price of sugammadex??
Conclusions
Sugammadex is a more efficacious reversal agent of
rocuronium than anticholinesterases
Replacement of anticholinesterases → benefits for the
patient, anaesthetist and surgeon
Suxamethonium may be replaced for R.S.I
Fewer s/e and c/i with rocuronium/sugammadex
More rapid onset-offset profile?
Routine use of sugammadex will depend upon economic
considerations
Sugammadex - a revolution in anaesthesia?
References
 Aitkenhead A.R., Smith G.m Rowbotham D.J. Textbook of Anaesthesia. 5th
ed. 2007. Churchill Livingstone Elsevier.
 Bettelli G. Which muscle relaxants should be used in day surgery and when. Curr Opin Anaesthesiol 2006; 19(6):600-605.
 de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg)
profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology 2007;
107(2):239-244.
 Donati F. Sugammadex: an opportunity for more thinking or more cookbook medicine? Can J Anaesth 2007; 54(9):689-695.
 Epemolu O, Bom A, Hope F, Mason R. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium
concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology 2003; 99(3):632-637.
 Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment.
Anesthesiology 2003; 98(5):1037-1039.
 Fields AM, Vadivelu N. Sugammadex: a novel neuromuscular blocker binding agent. Curr Opin Anaesthesiol 2007; 20(4):307-
310.
 Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L et al. Reversal of rocuronium-induced
neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Br J Anaesth
2008; 100(5):622-630.
 Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of
rocuronium bromide. Anesthesiology 2005; 103(4):695-703.
 Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia 2007; 62(8):806-809.
 Hunter JM, Flockton EA. The doughnut and the hole: a new pharmacological concept for anaesthetists. Br J Anaesth 2006;
97(2):123-126.
 Karcioglu O, Arnold J, Topacoglu H, Ozucelik DN, Kiran S, Sonmez N. Succinylcholine or rocuronium? A meta-analysis of the
effects on intubation conditions. Int J Clin Pract 2006; 60(12):1638-1646.
 Kopman AF. Sugammadex: a revolutionary approach to neuromuscular antagonism. Anesthesiology 2006; 104(4):631-633.
References
 Miller RD. Sugammadex: an opportunity to change the practice of anesthesiology? Anesth Analg 2007;
104(3):477-478.
 Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007;
104(3):575-581.
 Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y. Org 25969 (sugammadex), a
selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br
J Anaesth 2006; 96(1):36-43.
 Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME et al. Reversal of rocuronium-
induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and
safety study. Anesthesiology 2006; 104(4):667-674.
 Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V et al. Early reversal of profound
rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy,
safety, and pharmacokinetics. Anesthesiology 2007; 106(5):935-943.
 van Miert MM, Eastwood NB, Boyd AH, Parker CJ, Hunter JM. The pharmacokinetics and
pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Clin Pharmacol 1997; 44(2):139-
144.
 Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V et al. Reversal of
rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under
maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104(3):563-568.
 Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000;
84(3):301-303.

More Related Content

What's hot

Management of intraoperative bronchospasm
Management of intraoperative bronchospasmManagement of intraoperative bronchospasm
Management of intraoperative bronchospasmChaithanya Malalur
 
Spinal anesthesia in childeren
Spinal anesthesia in childerenSpinal anesthesia in childeren
Spinal anesthesia in childerenMohamed Ismail
 
Gas laws in anaesthesia
Gas laws in anaesthesiaGas laws in anaesthesia
Gas laws in anaesthesiaDavis Kurian
 
Neuromuscular Monitoring
Neuromuscular MonitoringNeuromuscular Monitoring
Neuromuscular MonitoringMohtasib Madaoo
 
anaesthesia in chronic kidney disease
anaesthesia in chronic kidney diseaseanaesthesia in chronic kidney disease
anaesthesia in chronic kidney diseasesarmistha panigrahi
 
Monitoring depth of anesthesia
Monitoring depth of anesthesiaMonitoring depth of anesthesia
Monitoring depth of anesthesiaRicha Kumar
 
Monitoring depth of anaesthesia
Monitoring depth of anaesthesiaMonitoring depth of anaesthesia
Monitoring depth of anaesthesiadr anurag giri
 
Low flow Anesthesia system
Low flow  Anesthesia systemLow flow  Anesthesia system
Low flow Anesthesia systemKIMS
 
Cerebral physiology and effects of anaesthetic agents
Cerebral physiology and effects of anaesthetic agentsCerebral physiology and effects of anaesthetic agents
Cerebral physiology and effects of anaesthetic agentsRicha Kumar
 
Muscle relaxant and reversal agents
Muscle relaxant and reversal agentsMuscle relaxant and reversal agents
Muscle relaxant and reversal agentsPranav Bansal
 
Magnesium sulphate and anesthesiologist
Magnesium sulphate and anesthesiologistMagnesium sulphate and anesthesiologist
Magnesium sulphate and anesthesiologistdr tushar chokshi
 
Intravenous Induction agents
Intravenous Induction agentsIntravenous Induction agents
Intravenous Induction agentssumanth reddy
 
post operative cognitive dysfunction
post operative cognitive dysfunctionpost operative cognitive dysfunction
post operative cognitive dysfunctionpriyanka gupta
 
Physiological changes in pregnancy & its anaesthetic implications
Physiological changes in pregnancy & its anaesthetic implicationsPhysiological changes in pregnancy & its anaesthetic implications
Physiological changes in pregnancy & its anaesthetic implicationsSwadheen Rout
 
anaesthesia for lap cholecystectomy
anaesthesia for lap cholecystectomyanaesthesia for lap cholecystectomy
anaesthesia for lap cholecystectomyabhijit wagh
 

What's hot (20)

Management of intraoperative bronchospasm
Management of intraoperative bronchospasmManagement of intraoperative bronchospasm
Management of intraoperative bronchospasm
 
Dexmedetomidine
DexmedetomidineDexmedetomidine
Dexmedetomidine
 
Spinal anesthesia in childeren
Spinal anesthesia in childerenSpinal anesthesia in childeren
Spinal anesthesia in childeren
 
Gas laws in anaesthesia
Gas laws in anaesthesiaGas laws in anaesthesia
Gas laws in anaesthesia
 
The canister (the absorber)
The canister (the absorber)The canister (the absorber)
The canister (the absorber)
 
Geriatric anaesthesia
Geriatric anaesthesiaGeriatric anaesthesia
Geriatric anaesthesia
 
Neuromuscular Monitoring
Neuromuscular MonitoringNeuromuscular Monitoring
Neuromuscular Monitoring
 
anaesthesia in chronic kidney disease
anaesthesia in chronic kidney diseaseanaesthesia in chronic kidney disease
anaesthesia in chronic kidney disease
 
Monitoring depth of anesthesia
Monitoring depth of anesthesiaMonitoring depth of anesthesia
Monitoring depth of anesthesia
 
Monitoring depth of anaesthesia
Monitoring depth of anaesthesiaMonitoring depth of anaesthesia
Monitoring depth of anaesthesia
 
Propofol ppt nandini
Propofol ppt nandiniPropofol ppt nandini
Propofol ppt nandini
 
Low flow Anesthesia system
Low flow  Anesthesia systemLow flow  Anesthesia system
Low flow Anesthesia system
 
Cerebral physiology and effects of anaesthetic agents
Cerebral physiology and effects of anaesthetic agentsCerebral physiology and effects of anaesthetic agents
Cerebral physiology and effects of anaesthetic agents
 
Muscle relaxant and reversal agents
Muscle relaxant and reversal agentsMuscle relaxant and reversal agents
Muscle relaxant and reversal agents
 
Magnesium sulphate and anesthesiologist
Magnesium sulphate and anesthesiologistMagnesium sulphate and anesthesiologist
Magnesium sulphate and anesthesiologist
 
Intravenous Induction agents
Intravenous Induction agentsIntravenous Induction agents
Intravenous Induction agents
 
post operative cognitive dysfunction
post operative cognitive dysfunctionpost operative cognitive dysfunction
post operative cognitive dysfunction
 
Physiological changes in pregnancy & its anaesthetic implications
Physiological changes in pregnancy & its anaesthetic implicationsPhysiological changes in pregnancy & its anaesthetic implications
Physiological changes in pregnancy & its anaesthetic implications
 
anaesthesia for lap cholecystectomy
anaesthesia for lap cholecystectomyanaesthesia for lap cholecystectomy
anaesthesia for lap cholecystectomy
 
ASRA Guidelines
ASRA GuidelinesASRA Guidelines
ASRA Guidelines
 

Viewers also liked

Controversias en reversión neuromuscular. Sugammadex
Controversias en reversión neuromuscular. SugammadexControversias en reversión neuromuscular. Sugammadex
Controversias en reversión neuromuscular. SugammadexJonathan Estévez Santiago
 
Neuromuscular blocking agents & reversal in anesthesia
Neuromuscular blocking agents & reversal in anesthesiaNeuromuscular blocking agents & reversal in anesthesia
Neuromuscular blocking agents & reversal in anesthesiamushtaq ahmad Malik
 
Neuro muscular blockers
Neuro muscular blockersNeuro muscular blockers
Neuro muscular blockersraj kumar
 
Bloqueadores Neuromusculares
Bloqueadores NeuromuscularesBloqueadores Neuromusculares
Bloqueadores Neuromuscularesavpantoja1
 
Stephen gatt
Stephen gattStephen gatt
Stephen gattDuy Quang
 
Depolarizing Neuromuscular Blockers
Depolarizing Neuromuscular BlockersDepolarizing Neuromuscular Blockers
Depolarizing Neuromuscular BlockersSara Memon
 
SUGAMMADEX, L’INHIBIDOR SELECTIU DELS AGENTS BLOCADORS NEUROMUSCULARS NO DESP...
SUGAMMADEX, L’INHIBIDOR SELECTIU DELS AGENTS BLOCADORS NEUROMUSCULARS NO DESP...SUGAMMADEX, L’INHIBIDOR SELECTIU DELS AGENTS BLOCADORS NEUROMUSCULARS NO DESP...
SUGAMMADEX, L’INHIBIDOR SELECTIU DELS AGENTS BLOCADORS NEUROMUSCULARS NO DESP...José Joaquín Machí Ribes
 
Bloqueo Neuromuscular. Monitoreo y Reversión
Bloqueo Neuromuscular. Monitoreo y ReversiónBloqueo Neuromuscular. Monitoreo y Reversión
Bloqueo Neuromuscular. Monitoreo y ReversiónNydia Báez
 
Sugammadex-Myasthenia Gravis
Sugammadex-Myasthenia GravisSugammadex-Myasthenia Gravis
Sugammadex-Myasthenia GravisCarlos D A Bersot
 
7ème Journée de la Recherche Clinique : Efficacy of Sugammadex...
 7ème Journée de la Recherche Clinique : Efficacy of Sugammadex... 7ème Journée de la Recherche Clinique : Efficacy of Sugammadex...
7ème Journée de la Recherche Clinique : Efficacy of Sugammadex...Hopitaux Universitaires de Genève
 
Redefining Education in America Cultivating Ethical & Moral Leadership
Redefining Education in America Cultivating Ethical & Moral LeadershipRedefining Education in America Cultivating Ethical & Moral Leadership
Redefining Education in America Cultivating Ethical & Moral LeadershipAnne Hamilton
 
International Institutions
International InstitutionsInternational Institutions
International Institutionsmeducationdotnet
 
Health Care Worker Migration
Health Care Worker MigrationHealth Care Worker Migration
Health Care Worker Migrationmeducationdotnet
 
Neuromuscular blocking agents in large animals
Neuromuscular blocking agents in large animalsNeuromuscular blocking agents in large animals
Neuromuscular blocking agents in large animalsAmen Deep
 
Updates in resuscitation.pptx ( hpp )
Updates in resuscitation.pptx ( hpp )Updates in resuscitation.pptx ( hpp )
Updates in resuscitation.pptx ( hpp )Azhar Mohamed
 

Viewers also liked (20)

Controversias en reversión neuromuscular. Sugammadex
Controversias en reversión neuromuscular. SugammadexControversias en reversión neuromuscular. Sugammadex
Controversias en reversión neuromuscular. Sugammadex
 
Neuromuscular blocking agents & reversal in anesthesia
Neuromuscular blocking agents & reversal in anesthesiaNeuromuscular blocking agents & reversal in anesthesia
Neuromuscular blocking agents & reversal in anesthesia
 
Neuro muscular blockers
Neuro muscular blockersNeuro muscular blockers
Neuro muscular blockers
 
Bloqueadores Neuromusculares
Bloqueadores NeuromuscularesBloqueadores Neuromusculares
Bloqueadores Neuromusculares
 
Stephen gatt
Stephen gattStephen gatt
Stephen gatt
 
Depolarizing Neuromuscular Blockers
Depolarizing Neuromuscular BlockersDepolarizing Neuromuscular Blockers
Depolarizing Neuromuscular Blockers
 
SUGAMMADEX, L’INHIBIDOR SELECTIU DELS AGENTS BLOCADORS NEUROMUSCULARS NO DESP...
SUGAMMADEX, L’INHIBIDOR SELECTIU DELS AGENTS BLOCADORS NEUROMUSCULARS NO DESP...SUGAMMADEX, L’INHIBIDOR SELECTIU DELS AGENTS BLOCADORS NEUROMUSCULARS NO DESP...
SUGAMMADEX, L’INHIBIDOR SELECTIU DELS AGENTS BLOCADORS NEUROMUSCULARS NO DESP...
 
No Title
No TitleNo Title
No Title
 
Bloqueo Neuromuscular. Monitoreo y Reversión
Bloqueo Neuromuscular. Monitoreo y ReversiónBloqueo Neuromuscular. Monitoreo y Reversión
Bloqueo Neuromuscular. Monitoreo y Reversión
 
BLOQUEADORES NEUROMUSCULARES
BLOQUEADORES NEUROMUSCULARESBLOQUEADORES NEUROMUSCULARES
BLOQUEADORES NEUROMUSCULARES
 
Sugammadex-Myasthenia Gravis
Sugammadex-Myasthenia GravisSugammadex-Myasthenia Gravis
Sugammadex-Myasthenia Gravis
 
7ème Journée de la Recherche Clinique : Efficacy of Sugammadex...
 7ème Journée de la Recherche Clinique : Efficacy of Sugammadex... 7ème Journée de la Recherche Clinique : Efficacy of Sugammadex...
7ème Journée de la Recherche Clinique : Efficacy of Sugammadex...
 
Redefining Education in America Cultivating Ethical & Moral Leadership
Redefining Education in America Cultivating Ethical & Moral LeadershipRedefining Education in America Cultivating Ethical & Moral Leadership
Redefining Education in America Cultivating Ethical & Moral Leadership
 
International Institutions
International InstitutionsInternational Institutions
International Institutions
 
Health Care Worker Migration
Health Care Worker MigrationHealth Care Worker Migration
Health Care Worker Migration
 
Neuromuscular blocking agents in large animals
Neuromuscular blocking agents in large animalsNeuromuscular blocking agents in large animals
Neuromuscular blocking agents in large animals
 
Updates in resuscitation.pptx ( hpp )
Updates in resuscitation.pptx ( hpp )Updates in resuscitation.pptx ( hpp )
Updates in resuscitation.pptx ( hpp )
 
Abdominal Exam
Abdominal ExamAbdominal Exam
Abdominal Exam
 
Respiratory System
Respiratory SystemRespiratory System
Respiratory System
 
Back Pain
Back PainBack Pain
Back Pain
 

Similar to Sugammadex - a revolution in anaesthesia?

sugmmadex.pptx
sugmmadex.pptxsugmmadex.pptx
sugmmadex.pptxTanPhan68
 
Actual Poster for SIP
Actual Poster for SIPActual Poster for SIP
Actual Poster for SIPRandy Cruz
 
Brief introduction to pulsed electro magnetic fields, preview of our workshop...
Brief introduction to pulsed electro magnetic fields, preview of our workshop...Brief introduction to pulsed electro magnetic fields, preview of our workshop...
Brief introduction to pulsed electro magnetic fields, preview of our workshop...ServaneCollette
 
Peripheral Nerve Catheters
Peripheral Nerve CathetersPeripheral Nerve Catheters
Peripheral Nerve CathetersDr.Mahmoud Abbas
 
Bone Metastases of Bone Metastases
Bone Metastases of Bone MetastasesBone Metastases of Bone Metastases
Bone Metastases of Bone MetastasesXiu Srithammasit
 
Ketamine In Emergency
Ketamine In EmergencyKetamine In Emergency
Ketamine In EmergencyAhmed Shalabi
 
Copy of skeletal muscle relaxants / dental implant courses
Copy of skeletal muscle relaxants / dental implant coursesCopy of skeletal muscle relaxants / dental implant courses
Copy of skeletal muscle relaxants / dental implant coursesIndian dental academy
 
The anesthetic pipeline
The anesthetic pipelineThe anesthetic pipeline
The anesthetic pipelinezedding
 
Monitoring solutions entropy publications reference list august 2016
Monitoring solutions entropy publications reference list august 2016Monitoring solutions entropy publications reference list august 2016
Monitoring solutions entropy publications reference list august 2016grattoanestesista
 
botulinum toxin and appropriate modulation of spasticity
botulinum toxin and appropriate modulation of spasticity botulinum toxin and appropriate modulation of spasticity
botulinum toxin and appropriate modulation of spasticity giankaianieri
 
Reduced Short- and Long-Latency Afferent Inhibition Following Acute Muscle Pa...
Reduced Short- and Long-Latency Afferent Inhibition Following Acute Muscle Pa...Reduced Short- and Long-Latency Afferent Inhibition Following Acute Muscle Pa...
Reduced Short- and Long-Latency Afferent Inhibition Following Acute Muscle Pa...Antonio Martinez
 
muscle relaxants / oral surgery courses
muscle relaxants / oral surgery courses muscle relaxants / oral surgery courses
muscle relaxants / oral surgery courses Indian dental academy
 
Mottin laporte-cespuglio-2003
Mottin laporte-cespuglio-2003Mottin laporte-cespuglio-2003
Mottin laporte-cespuglio-2003Stéphane MOTTIN
 

Similar to Sugammadex - a revolution in anaesthesia? (20)

sugmmadex.pptx
sugmmadex.pptxsugmmadex.pptx
sugmmadex.pptx
 
Actual Poster for SIP
Actual Poster for SIPActual Poster for SIP
Actual Poster for SIP
 
Brief introduction to pulsed electro magnetic fields, preview of our workshop...
Brief introduction to pulsed electro magnetic fields, preview of our workshop...Brief introduction to pulsed electro magnetic fields, preview of our workshop...
Brief introduction to pulsed electro magnetic fields, preview of our workshop...
 
Muscle relaxants
Muscle relaxantsMuscle relaxants
Muscle relaxants
 
Peripheral Nerve Catheters
Peripheral Nerve CathetersPeripheral Nerve Catheters
Peripheral Nerve Catheters
 
3.1 Amman 2011.pdf
3.1 Amman 2011.pdf3.1 Amman 2011.pdf
3.1 Amman 2011.pdf
 
Bone Metastases of Bone Metastases
Bone Metastases of Bone MetastasesBone Metastases of Bone Metastases
Bone Metastases of Bone Metastases
 
Neuromuscular blocking
Neuromuscular blockingNeuromuscular blocking
Neuromuscular blocking
 
Cytotron 2
Cytotron 2Cytotron 2
Cytotron 2
 
Ketamine In Emergency
Ketamine In EmergencyKetamine In Emergency
Ketamine In Emergency
 
Myasthenia Gravis - Management
Myasthenia Gravis - ManagementMyasthenia Gravis - Management
Myasthenia Gravis - Management
 
Copy of skeletal muscle relaxants / dental implant courses
Copy of skeletal muscle relaxants / dental implant coursesCopy of skeletal muscle relaxants / dental implant courses
Copy of skeletal muscle relaxants / dental implant courses
 
The anesthetic pipeline
The anesthetic pipelineThe anesthetic pipeline
The anesthetic pipeline
 
TMS Dissertation 2013
TMS Dissertation 2013TMS Dissertation 2013
TMS Dissertation 2013
 
Monitoring solutions entropy publications reference list august 2016
Monitoring solutions entropy publications reference list august 2016Monitoring solutions entropy publications reference list august 2016
Monitoring solutions entropy publications reference list august 2016
 
botulinum toxin and appropriate modulation of spasticity
botulinum toxin and appropriate modulation of spasticity botulinum toxin and appropriate modulation of spasticity
botulinum toxin and appropriate modulation of spasticity
 
Reduced Short- and Long-Latency Afferent Inhibition Following Acute Muscle Pa...
Reduced Short- and Long-Latency Afferent Inhibition Following Acute Muscle Pa...Reduced Short- and Long-Latency Afferent Inhibition Following Acute Muscle Pa...
Reduced Short- and Long-Latency Afferent Inhibition Following Acute Muscle Pa...
 
Residual neuromascular blockade,hpoxia in PACU
Residual neuromascular blockade,hpoxia in PACUResidual neuromascular blockade,hpoxia in PACU
Residual neuromascular blockade,hpoxia in PACU
 
muscle relaxants / oral surgery courses
muscle relaxants / oral surgery courses muscle relaxants / oral surgery courses
muscle relaxants / oral surgery courses
 
Mottin laporte-cespuglio-2003
Mottin laporte-cespuglio-2003Mottin laporte-cespuglio-2003
Mottin laporte-cespuglio-2003
 

More from meducationdotnet

Water and sanitation and their impact on health
Water and sanitation and their impact on healthWater and sanitation and their impact on health
Water and sanitation and their impact on healthmeducationdotnet
 
Haemochromotosis brief overview
Haemochromotosis brief overviewHaemochromotosis brief overview
Haemochromotosis brief overviewmeducationdotnet
 
Overview of Antidepressants
Overview of AntidepressantsOverview of Antidepressants
Overview of Antidepressantsmeducationdotnet
 
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Review of orthopaedic services: Prepared for the Auditor General for Scotland...Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Review of orthopaedic services: Prepared for the Auditor General for Scotland...meducationdotnet
 
Interstitial and restrictive lung diseases
Interstitial and restrictive lung diseasesInterstitial and restrictive lung diseases
Interstitial and restrictive lung diseasesmeducationdotnet
 
New biochemical markers of risk of Coronary Heart Disease (CHD)
New biochemical markers of risk of Coronary Heart Disease (CHD)New biochemical markers of risk of Coronary Heart Disease (CHD)
New biochemical markers of risk of Coronary Heart Disease (CHD)meducationdotnet
 

More from meducationdotnet (20)

Spondylarthropathy
SpondylarthropathySpondylarthropathy
Spondylarthropathy
 
Diagnosing Lung cancer
Diagnosing Lung cancerDiagnosing Lung cancer
Diagnosing Lung cancer
 
Eczema Herpeticum
Eczema HerpeticumEczema Herpeticum
Eczema Herpeticum
 
The Vagus Nerve
The Vagus NerveThe Vagus Nerve
The Vagus Nerve
 
Water and sanitation and their impact on health
Water and sanitation and their impact on healthWater and sanitation and their impact on health
Water and sanitation and their impact on health
 
The ethics of electives
The ethics of electivesThe ethics of electives
The ethics of electives
 
Intro to Global Health
Intro to Global HealthIntro to Global Health
Intro to Global Health
 
WTO and Health
WTO and HealthWTO and Health
WTO and Health
 
Globalisation and Health
Globalisation and HealthGlobalisation and Health
Globalisation and Health
 
Haemochromotosis brief overview
Haemochromotosis brief overviewHaemochromotosis brief overview
Haemochromotosis brief overview
 
Ascities overview
Ascities overviewAscities overview
Ascities overview
 
Overview of the Liver
Overview of the LiverOverview of the Liver
Overview of the Liver
 
Overview of Antidepressants
Overview of AntidepressantsOverview of Antidepressants
Overview of Antidepressants
 
Gout Presentation
Gout PresentationGout Presentation
Gout Presentation
 
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Review of orthopaedic services: Prepared for the Auditor General for Scotland...Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
 
Ophthamology Revision
Ophthamology RevisionOphthamology Revision
Ophthamology Revision
 
Dermatology Atlas
Dermatology AtlasDermatology Atlas
Dermatology Atlas
 
Interstitial and restrictive lung diseases
Interstitial and restrictive lung diseasesInterstitial and restrictive lung diseases
Interstitial and restrictive lung diseases
 
New biochemical markers of risk of Coronary Heart Disease (CHD)
New biochemical markers of risk of Coronary Heart Disease (CHD)New biochemical markers of risk of Coronary Heart Disease (CHD)
New biochemical markers of risk of Coronary Heart Disease (CHD)
 
i-LIMB Bionic Hand
i-LIMB Bionic Handi-LIMB Bionic Hand
i-LIMB Bionic Hand
 

Sugammadex - a revolution in anaesthesia?

  • 2. Why are muscle relaxants used? Facilitation of tracheal intubation Rapid sequence induction Paralysis important for certain types of surgery E.g. abdominal Prevents patient movement during delicate surgery E.g. Neuro or ocular Allows patient’s ventilation to be controlled ITU
  • 3. Muscle Relaxants Depolarising Suxamethonium Rapid onset and offset Not pharmacologically reversible Numerous s/e and c/i Non-depolarising Compete with ACh for binding at the α subunit of the nAChR Blockade can be reversed with anticholinesterase Drug Onset (s) Offset (min) Suxamethonium 60 10 Atracurium 110 43 Mivacurium 170 16 Rocuronium 75 33 Vecuronium 180 33 Modified from Aitkenhead et al.
  • 5. Neuromuscular monitoring Allows indirect determination of neuromuscular transmission Should be performed whenever a NMB is used (Eriksson et al. 2003) Train-of-four (TOF) twitch response Electric current applied in bursts of 4 to the ulnar nerve Response in adductor policis measured (acceleromyography) NDMB causes fade in the amplitude of the twitches 4th twitch affected first then 3nd , 2nd and 1st Ratio of amplitude of 4th :1st twitch = TOF ratio
  • 6. Train-of-four TOF ratio for safe extubation is 0.9 (Viby- Mogensen 2000) 2nd twitch must be visible for anticholinesterase reversal to be effective (van Miert et al. 1997) Atracurium
  • 7. Current problems Sux. has rapid onset and offset but many s/e and often c/i What would the alternative be for R.S.I? Rocuronium has rapid onset but in a ‘cannot intubate cannot ventilate’ situation return to spontaneous breathing is too slow Reversal of profound ND blockade is not possible PORC vs inadequate blockade Lack NM monitoring despite recommendation → unrecognised PORC (Grayling 2007, Eriksson 2003) Reversal with neostigmine/edrophonium + parasympatholytic cumbersome. CVS effects and PONV.
  • 8. The answer – sugammadex? A γ cyclodextrin molecule composed of 8 glucose mols forming a ring Designed to encapsulate aminosteroid NDMBs, especially rocuronium (rocuronium>vecuronium>>pancuronium) Sugammadex binds rocuronium v tightly and irreversibly in a 1:1 ratio forming an H2O soluble complex (Hunter et al. 2006) (Naguib 2007)
  • 10. Sugammadex – mechanism of action Sugammadex has its action in the plasma, not at the NMJ Rocuronium is encapsulated in the plasma Concentration gradient between free rocuronium in the plasma and rocuronium at the NMJ Rocuronium diffuses away from the NMJ into the plasma where it is chelated by sugammadex nAChRs become free at the NMJ allowing neuromuscular transmission to resume Gijsenbergh et al. 2005
  • 11. Better than anticholinesterase? Flockton et al. 2008 Compared time to recovery of TOF 0.9  Rocuronium 0.6mgkg-1 followed by sugammadex 2mgkg-1  Cisatracurium 0.15mgkg-1 followed by neostigmine 50μgkg-1 Reversal given at appearance of T2 Mean time to recovery  Rocuronium/sugammadex 1.9 min  Cisatracurium/neostigmine 9.0 min (p<0.0001) Greater change in HR in neostigmine group (glycopyrrolate)
  • 12. Reversal of profound block Standard anticholinesterases only effective after appearance of T2 Sparr et al. 2007 98 anaesthetised patients given rocuronium 0.6mgkg-1 Randomised to varying doses of sugammadex or placebo 3, 5 or 15 mins after rocuronium Recovery to 0.9 TOF reduced from 52.1 mins to 1.8 mins when 8mgkg-1 sugammadex given 3mins after rocuronium
  • 13. Better than suxamethonium? Naguib et al. 2007 Compare speed of recovery from 1.2mgkg-1 rocuronium followed 3 mins later by 16mgkg-1 sugammadex with spontaneous recovery from 1mgkg-1 suxmaethonium Total onset-offest time is faster for rocuronium/sugammadex (4min 47) than suxamethonium (9min 23) Suxamethonium produces superior intubating conditions compared to rocuronium (Karcioglu et al. 2006)
  • 14. Is sugammadex safe? No serious adverse effects have been reported to date QT ↑ (Gijsenbergh et al.), transient BP↓ (de Boer et al.) and ↑ urinary N-acetyl glucosaminidase (Flockton et al.) Rocuronium/sugammadex excreted mainly in the urine (Gijsenbergh et al.) – renal failure? No known effect on any receptor system, no need for anti-muscarinic – cardiovascular stability Equally effective under maintenance anaesthesia with propofol as sevoflurane (unlike neostigmine) (Vanacker et al. 2007)
  • 15. Applications More rapid reversal than anticholinesterases with fewer s/e More rapid turnaround of surgical patients Ability to antagonise a profound block Larger doses of rocuronium can be used with confidence Less PORC in the absence of neuromuscular monitoring Rapid onset-offset of rocuronium/sugammadex Could replace suxamethonium for R.S.I
  • 16. Considerations Ethical Rocuronium and sugammadex manufactured by Organon Temptation to rely on rocuronium Consider the patient Advancement for advancement’s sake or real benefits? Economic Potential to use larger doses of rocuronium Price of sugammadex??
  • 17. Conclusions Sugammadex is a more efficacious reversal agent of rocuronium than anticholinesterases Replacement of anticholinesterases → benefits for the patient, anaesthetist and surgeon Suxamethonium may be replaced for R.S.I Fewer s/e and c/i with rocuronium/sugammadex More rapid onset-offset profile? Routine use of sugammadex will depend upon economic considerations
  • 19. References  Aitkenhead A.R., Smith G.m Rowbotham D.J. Textbook of Anaesthesia. 5th ed. 2007. Churchill Livingstone Elsevier.  Bettelli G. Which muscle relaxants should be used in day surgery and when. Curr Opin Anaesthesiol 2006; 19(6):600-605.  de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology 2007; 107(2):239-244.  Donati F. Sugammadex: an opportunity for more thinking or more cookbook medicine? Can J Anaesth 2007; 54(9):689-695.  Epemolu O, Bom A, Hope F, Mason R. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology 2003; 99(3):632-637.  Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology 2003; 98(5):1037-1039.  Fields AM, Vadivelu N. Sugammadex: a novel neuromuscular blocker binding agent. Curr Opin Anaesthesiol 2007; 20(4):307- 310.  Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L et al. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Br J Anaesth 2008; 100(5):622-630.  Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103(4):695-703.  Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia 2007; 62(8):806-809.  Hunter JM, Flockton EA. The doughnut and the hole: a new pharmacological concept for anaesthetists. Br J Anaesth 2006; 97(2):123-126.  Karcioglu O, Arnold J, Topacoglu H, Ozucelik DN, Kiran S, Sonmez N. Succinylcholine or rocuronium? A meta-analysis of the effects on intubation conditions. Int J Clin Pract 2006; 60(12):1638-1646.  Kopman AF. Sugammadex: a revolutionary approach to neuromuscular antagonism. Anesthesiology 2006; 104(4):631-633.
  • 20. References  Miller RD. Sugammadex: an opportunity to change the practice of anesthesiology? Anesth Analg 2007; 104(3):477-478.  Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007; 104(3):575-581.  Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006; 96(1):36-43.  Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME et al. Reversal of rocuronium- induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006; 104(4):667-674.  Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007; 106(5):935-943.  van Miert MM, Eastwood NB, Boyd AH, Parker CJ, Hunter JM. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Clin Pharmacol 1997; 44(2):139- 144.  Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104(3):563-568.  Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000; 84(3):301-303.